Skip to main content
. 2019 Jun 2;10(14):3188–3196. doi: 10.7150/jca.30281

Table 2.

The characteristics of the 468 patients grouped by NLR, PLR and MLR

Cases (number, %) NLR (number) P value PLR (number) P value MLR (number) P value
468 (100) <2.27 ≥2.27 <117.05 ≥117.05 <0.19 ≥0.19
Gender 0.005* 0.172 0.223
Male 376 (80.3) 266 126 259 117 238 138
Female 92 (19.7) 75 17 56 36 65 27
Age (years) 0.349 0.490 0.562
≤60 247 (52.8) 175 72 170 77 163 84
>60 221 (47.2) 166 55 145 76 140 81
Smoking 0.917 0.428 0.560
Ever 209 (44.7) 153 56 145 64 132 77
Never 259 (55.3) 188 71 170 89 171 88
Drinking 0.287 0.615 0.921
Yes 286 (61.1) 203 83 195 91 186 100
No 182 (38.9) 138 44 120 62 117 65
Tumor length 0.020* 0.128 0.010*
≤3 70 (15) 59 11 53 17 55 15
>3 398 (85) 282 116 262 136 248 150
Tumor location 0.670 0.922 0.670
Upper 62 (13.2) 47 15 43 19 47 15
Middle 228 (48.7) 162 66 152 76 162 66
Lower 178 (38.0) 132 46 120 58 132 46
Differentiation 0.274 0.972 0.260
Well 123 (26.3) 92 31 82 41 87 36
Moderate 233 (49.8) 174 59 158 75 147 86
Poor 112 (23.9) 75 37 75 37 69 43
T stage 0.010* 0.727 0.024*
T1 46 (9.8) 41 5 32 14 34 12
T2 77 (16.5) 49 28 54 23 47 30
T3 274 (58.5) 204 70 185 89 186 88
T4 71 (15.2) 47 24 44 27 36 35
N stage 0.988 0.634 0.398
N0 238 (50.9) 173 65 156 82 158 80
N1 129 (27.6) 95 34 91 38 86 43
N2 74 (15.8) 54 20 48 26 45 29
N3 27 (5.8) 19 8 20 7 14 13
TNM stage 0.204 0.278 0.228
I 46 (9.8) 38 8 33 13 35 11
II 199 (42.5) 139 60 126 73 125 74
III 223 (47.6) 164 59 156 67 143 80
Operation time (min) 0.077 0.163 0.696
<200 200 (42.9) 153 47 142 58 132 68
≥200 268 (57.1) 188 80 173 95 171 97
Intraoperative blood loss (ml) 0.253 1.000 0.698
<200 220 (47.0) 166 54 148 72 140 80
≥200 248 (53.0) 175 73 167 81 163 85

*P less than 0.05 is significant.

NLR = neutrophil-lymphocyte ratio; PLR = platelet-lymphocyte ratio; MLR = monocyte-lymphocyte ratio.